about
The linear no-threshold relationship is inconsistent with radiation biologic and experimental dataRadiation hormesis: historical perspective and implications for low-dose cancer risk assessmentThe effects of G2-phase enrichment and checkpoint abrogation on low-dose hyper-radiosensitivitySurgical management of giant secondary malignant fibrous histiocytoma following radiotherapy for nasopharyngeal carcinoma: A case report and literature review.Review and evaluation of updated research on the health effects associated with low-dose ionising radiation.Sensitivity to low-dose/low-LET ionizing radiation in mammalian cells harboring mutations in succinate dehydrogenase subunit C is governed by mitochondria-derived reactive oxygen speciesDynamics of cellular responses to radiation.Radiobiological Response of Cervical Cancer Cell Line in Low Dose Region: Evidence of Low Dose Hypersensitivity (HRS) and Induced Radioresistance (IRR)Contribution of Dual Oxidase 2 (DUOX2) to Hyper-Radiosensitivity in Human Gastric Cancer Cells.Association of ATM activation and DNA repair with induced radioresistance after low-dose irradiation.MRI evaluation of neoadjuvant low-dose fractionated radiotherapy with concurrent chemotherapy in patients with locally advanced breast cancer.Second malignant neoplasms following radiotherapy.Non-problematic risks from low-dose radiation-induced DNA damage clustersImpact of time interval and dose rate on cell survival following low-dose fractionated exposures.Different dose rate-dependent responses of human melanoma cells and fibroblasts to low dose fast neutrons.Vibrational spectroscopy in sensing radiobiological effects: analyses of targeted and non-targeted effects in human keratinocytes.Determining if low dose hyper-radiosensitivity (HRS) can be exploited to provide a therapeutic advantage: a cell line study in four glioblastoma multiforme (GBM) cell lines.Impact of dose-rate on the low-dose hyper-radiosensitivity and induced radioresistance (HRS/IRR) response.Different involvement of autophagy in human malignant glioma cell lines undergoing irradiation and temozolomide combined treatments.Low-dose hyper-radiosensitivity of progressive and regressive cells isolated from a rat colon tumour: impact of DNA repair.Vorinostat(SAHA) Promotes Hyper-Radiosensitivity in Wild Type p53 Human Glioblastoma Cells.External beam pulsed low dose radiotherapy using volumetric modulated arc therapy: planning and delivery.Relative biological effectiveness and cell-killing efficacy of continuous low-dose-rate 125I seeds on prostate carcinoma cells in vitro.
P2860
Q24649840-45B4B0EA-F968-4F6F-9F51-30D25C9FF042Q28396363-928DDC4C-167A-4755-9401-285E24E045D8Q28569166-FDB02B47-2503-4230-958D-5768EC214E0AQ33778418-A0C4CA2E-501C-4338-B876-8DA35104DDE0Q34111610-4EB4B37E-D257-480D-B6E6-237F1E36C4E7Q34822379-3089B719-AE23-4227-9119-8D2C408E6F22Q35145051-BFCCA54F-4284-4132-A58A-51032541F95CQ35918265-40A3802E-B3F1-4AEC-AED2-2FB5A3E326F3Q35996764-B6DDCC5B-CBDE-4EB6-9520-2C52BDC1FCFAQ36065662-985018A4-E608-44B0-946E-4206B198EB1DQ36407155-10614BF6-DDEA-441D-850B-B4B2CCE0ABEAQ36538754-FC5AA7A1-3415-45BB-804A-24C950F389C7Q36781044-D9699D6B-DB25-43F6-B935-37CD9DB3179CQ38700842-3C552C3A-9000-4309-BFB4-A3F2705386F5Q38766819-2FD1C7C0-23A8-4C1D-8082-36608FE56882Q38780810-2610FD63-F6A5-4E2F-80A9-DF956ED2955FQ39125187-B2F6CC14-C6B5-46FC-A356-7171654A5669Q39158210-AFFE95CF-498D-419F-A1C5-DFAD60100C23Q39394543-AF6C0C15-E5EE-40B0-8E1D-4B3812B3C29BQ39956755-D950563D-269C-47E3-8829-99D258352042Q42974434-5A551E34-8E3F-4F23-A11B-5FD87A9F82D4Q45161306-1A04D957-47BE-435B-B0EF-6FD62FF77153Q53342461-4BDEBC11-4607-4686-9F31-0399A84B0913
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Role of apoptosis in low-dose hyper-radiosensitivity.
@en
type
label
Role of apoptosis in low-dose hyper-radiosensitivity.
@en
prefLabel
Role of apoptosis in low-dose hyper-radiosensitivity.
@en
P2093
P356
P1433
P1476
Role of apoptosis in low-dose hyper-radiosensitivity.
@en
P2093
Krueger SA
Piasentin E
Weinfeld M
P304
P356
10.1667/RR0776.1
P577
2007-03-01T00:00:00Z